In short. Solar lentigines are sharply defined, flat, tan to dark brown patches on skin with years of sun exposure. Unlike freckles they do not fade when sun exposure falls, and unlike lentigo maligna they stay stable — which is why any changing lesion is examined before treatment.
Key points
- Solar lentigines are permanent sun-induced patches; freckles fade with less sun, these do not.
- Chronic ultraviolet exposure raises melanocyte numbers and melanin output, so pigment persists year-round.
- Dermoscopy resolves most lesions; a small sample is examined where doubt remains.
- Topical agents lighten modestly and slowly; light and laser devices clear faster.
- Without daily photoprotection, new spots form and treated areas darken again.
What solar lentigines are
Solar lentigines — sun spots, sun-induced freckles, or the misleadingly named liver spots — are sharply defined, flat, tan to dark brown patches on skin that has seen years of sun. They appear on the face, the backs of the hands, the forearms, the chest and shoulders, and the scalp of balding men. They are the visible record of cumulative ultraviolet exposure, and they usually begin to appear in the thirties and forties and accumulate with age.
They are not caused by the liver, and they have nothing to do with liver disease. The name is a historical mistake that has outlived its usefulness. What actually happens is that chronic ultraviolet exposure increases both the number of melanocytes in the area and their melanin production, so the pigment becomes permanent rather than seasonal.
How does a sun spot differ from a freckle or a melanoma?
The distinction from freckles is behavioural: freckles fade when sun exposure falls, sun spots do not. The distinction that matters more is from lesions that are not benign.
| Solar lentigo | Freckle | Lentigo maligna | |
|---|---|---|---|
| What it is | Pigment patch from cumulative UV | Small flat spot that follows sun exposure | Melanoma in situ on sun-damaged skin |
| With less sun | Persists | Fades | Enlarges and darkens slowly |
| Outline | Sharply defined | Small, flat | Becomes irregular or notched |
| Surface | Flat | Flat | Flat, changing over time |
| Action | Diagnose, then treat | No treatment needed | Urgent assessment and biopsy |
| Risk if missed | Benign | Benign | Melanoma in situ |
A seborrhoeic keratosis — a harmless, waxy, slightly raised growth — is often mistaken for a sun spot by patients. More importantly, lentigo maligna, a form of melanoma in situ that favours chronically sun-damaged facial skin, begins as a flat brown patch that looks very much like a large sun spot and slowly enlarges and darkens.
Diagnosis comes before treatment
Because a harmless sun spot and an early melanoma can look alike on sun-damaged skin, the assessment comes first. Dermoscopy — examination with a magnifying, polarised instrument — resolves most of these lesions without cutting anything. Where doubt remains, a small sample is taken and examined under the microscope. Lasering a lesion that has not been diagnosed removes the evidence along with the pigment.
What actually fades sun spots?
Topical agents that interrupt melanin production lighten sun spots modestly and slowly, and they work better in combination than alone. Light and laser devices targeting melanin clear them faster and more completely, often in a small number of sessions, and cryotherapy is sometimes used for individual lesions. Results are real.
Why do treated spots come back?
So is recurrence: without daily photoprotection, new spots form and treated areas darken again, and the cycle repeats. Prevention is therefore not an afterthought. Broad-spectrum sunscreen used consistently, protective clothing, and avoiding the strongest midday sun reduce the rate at which new lesions appear, and lower the risk of the skin cancers that share the same cause.
When should a lesion be examined before treatment?
- A flat brown patch is enlarging slowly, deepening in colour, or developing an irregular or notched edge.
- A lesion is raised, waxy, or looks stuck onto the skin — that may be a different diagnosis entirely.
- There is bleeding, itching, crusting, or a sore that will not heal.
Sources
- American Academy of Dermatology — solar lentigines (sun spots) overview
- NICE — suspected cancer recognition and referral guidance
- British Association of Dermatologists — lentigo maligna patient information
Internal links
Frequently asked questions
Are sun spots dangerous?
Most are harmless, but lentigo maligna, a form of melanoma in situ, begins as a flat brown patch on chronically sun-damaged facial skin that looks very much like a large sun spot. Diagnosis therefore comes before treatment, because lasering an undiagnosed lesion removes the evidence.
What actually fades sun spots?
Topical agents that interrupt melanin production lighten them modestly and slowly, and they work better in combination than alone. Light and laser devices targeting melanin clear them faster, often in a small number of sessions, and cryotherapy is sometimes used for individual lesions.
Do sun spots come back after treatment?
Yes. Results are real, but so is recurrence: without daily photoprotection, new spots form and treated areas darken again. Broad-spectrum sunscreen used consistently, protective clothing and avoiding the strongest midday sun reduce the rate at which new lesions appear.
Risks & Limitations
- Most chronic skin disease is managed rather than cured, and relapse is expected.
- Treatments typically need 8–12 weeks before response can be judged fairly.
- Topical treatment can cause irritation, dryness, peeling and photosensitivity.
- Systemic therapy may require blood monitoring and carries organ, metabolic and pregnancy risks.
- Isotretinoin in particular requires strict monitoring and pregnancy prevention.
- Pigment change is often slow and may be incomplete.
- No treatment works for everyone, and response cannot be predicted with certainty.
When to Seek Care
- A mole or lesion that changes in size, shape or colour, or starts to bleed, itch or crust.
- Fever with a widespread rash, blistering, or rash involving the eyes, mouth or genitals — seek emergency care.
- Rapidly spreading redness, swelling or pain in the skin.
- Facial swelling or difficulty breathing — possible severe reaction; seek emergency care immediately.
- New or worsening symptoms while taking a monitored medication.
References & Further Reading
- American Academy of Dermatology (AAD) — public and clinical guidance
- World Health Organization (WHO) — skin and infectious disease resources
- Chinese Medical Association, Dermatology Branch — clinical guidance
- Cochrane Library — systematic reviews in dermatology
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.